Mangoceuticals (MGRX) Equity Average (2023 - 2025)
Historic Equity Average for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $17.5 million.
- Mangoceuticals' Equity Average rose 2848.43% to $17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year increase of 2848.43%. This contributed to the annual value of $7.4 million for FY2024, which is N/A changed from last year.
- Per Mangoceuticals' latest filing, its Equity Average stood at $17.5 million for Q3 2025, which was up 2848.43% from $19.7 million recorded in Q2 2025.
- Mangoceuticals' Equity Average's 5-year high stood at $19.7 million during Q2 2025, with a 5-year trough of -$91857.0 in Q1 2024.
- Its 3-year average for Equity Average is $10.1 million, with a median of $13.6 million in 2024.
- Within the past 5 years, the most significant YoY rise in Mangoceuticals' Equity Average was 1871478.66% (2025), while the steepest drop was 2848.43% (2025).
- Over the past 3 years, Mangoceuticals' Equity Average (Quarter) stood at $1.1 million in 2023, then surged by 1183.61% to $13.7 million in 2024, then increased by 27.94% to $17.5 million in 2025.
- Its Equity Average was $17.5 million in Q3 2025, compared to $19.7 million in Q2 2025 and $17.1 million in Q1 2025.